Variant report
Variant | esv2760968 |
---|---|
Chromosome Location | chr5:58038804-58040137 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:57946400..57947922-chr5:58037144..58039712,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs292948 | chr5:58038804-58038805 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs556281598 | chr5:58038817-58038818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577730539 | chr5:58038869-58038870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544962997 | chr5:58038900-58038901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564625531 | chr5:58038963-58038964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528740414 | chr5:58038991-58038992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573888664 | chr5:58038993-58038994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35762639 | chr5:58038996-58038997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540559532 | chr5:58039018-58039019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142006136 | chr5:58039022-58039023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560258168 | chr5:58039023-58039024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7729997 | chr5:58039138-58039139 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs550694870 | chr5:58039192-58039193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79050437 | chr5:58039220-58039221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568974164 | chr5:58039227-58039228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376702969 | chr5:58039249-58039250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533192655 | chr5:58039260-58039261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551713330 | chr5:58039321-58039322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146912480 | chr5:58039344-58039345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553332969 | chr5:58039388-58039389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186043354 | chr5:58039405-58039406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368931418 | chr5:58039407-58039408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545921106 | chr5:58039429-58039430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564601405 | chr5:58039594-58039595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555351782 | chr5:58039639-58039640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs720084 | chr5:58039641-58039642 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs7734741 | chr5:58039681-58039682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6895906 | chr5:58039686-58039687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs562108314 | chr5:58039762-58039763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570941766 | chr5:58039766-58039767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139230040 | chr5:58039784-58039785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577767749 | chr5:58039794-58039795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544686499 | chr5:58039797-58039798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529466015 | chr5:58039883-58039884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539573684 | chr5:58039899-58039900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547661277 | chr5:58039943-58039944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549860183 | chr5:58039967-58039968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7720815 | chr5:58039977-58039978 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs529461671 | chr5:58040023-58040024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143232683 | chr5:58040038-58040039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74799340 | chr5:58040101-58040102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6876953 | chr5:58040112-58040113 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs188397281 | chr5:58040122-58040123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79656109 | chr5:58040125-58040126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:58027800-58049400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:58031800-58041400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:58036000-58040600 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr5:58036000-58040800 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr5:58038000-58039000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:58038000-58039000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr5:58038200-58039000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr5:58038200-58039000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr5:58039000-58041400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr5:58039000-58041600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |